Dengvaxia, četverovalentno cjepivo protiv denge (živo, atenuirano)
The medicinal product has been authorised by the European Commission (EC) via centralised procedure in all EU Member States, based on the European Medicines Agency (EMA) experts' opinion.
| Name | Dengvaxia, četverovalentno cjepivo protiv denge (živo, atenuirano) |
|---|---|
| Active Substance | kimerički virus žute groznice/denge serotipa 1 (živi, atenuirani) kimerički virus žute groznice/denge serotipa 2 (živi, atenuirani) kimerički virus žute groznice/denge serotipa 3 (živi, atenuirani) kimerički virus žute groznice/denge serotipa 4 (živi, atenuirani) |
| Prescription | na recept |
| Type of prescription | ograničeni recept |
| Distribution | u ljekarni |
| ATC Code | J07BX04 |
| Summary of product characteristics (SmPC), labelling and package leaflet (PL) | download |
| Link to the European Medicines Agency's (EMA) product information | download |
| Link to the European Commission's (EC) decisions | download |
